Medical researchers have linked the specific biochemical changes to a protein called CHIP to specific disease characteristics of patients with a wide range of rare disorders. The research shows it is possible to merge analyses of protein biochemistry with patient characteristics to better understand spinocerebellar ataxia autosomal recessive 16, or SCAR16.